Fmr LLC Aurinia Pharmaceuticals Inc. Transaction History

Fmr LLC

$1.81 Trillion
Q3 2025

A detailed history of Fmr LLC transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Fmr LLC holds 218,266 shares of AUPH stock, worth $3.35 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

218,266

Previous 158,693 37.54%

Holding current value

$3.35 Million

Previous $1.34 Million 79.39%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$7.47 - $13.14 $445,010 - $782,789	59,573 Added 37.54%	218,266 $2.41 Million
Q2 2025 Aug 14, 2025	BUY	$7.2 - $8.64 $422,697 - $507,237	58,708 Added 58.72%	158,693 $1.34 Million
Q1 2025 May 12, 2025	SELL	$7.55 - $8.77 $598,050 - $694,689	-79,212 Reduced 44.2%	99,985 $803,000
Q4 2024 Feb 13, 2025	BUY	$6.75 - $10.44 $1.12 Million - $1.74 Million	166,524 Added 1314.01%	179,197 $1.61 Million
Q3 2024 Nov 13, 2024	BUY	$5.32 - $7.33 $20,849 - $28,726	3,919 Added 44.77%	12,673 $92,000

Q2 2024 Aug 13, 2024	BUY	$4.81 - $5.78 $9,004 - $10,820	1,872 Added 27.2%	8,754 $49,000
Q1 2024 May 13, 2024	SELL	$4.93 - $9.31 $4,875 - $9,207	-989 Reduced 12.57%	6,882 $34,000
Q4 2023 Feb 13, 2024	SELL	$7.13 - $9.49 $6,452 - $8,588	-905 Reduced 10.31%	7,871 $70,000
Q3 2023 Nov 13, 2023	SELL	$7.77 - $12.27 $112,276 - $177,301	-14,450 Reduced 62.21%	8,776 $68,000
Q2 2023 Aug 11, 2023	BUY	$8.96 - $11.69 $129,561 - $169,037	14,460 Added 164.96%	23,226 $224,000
Q1 2023 May 11, 2023	BUY	$5.94 - $11.27 $21,538 - $40,865	3,626 Added 70.54%	8,766 $96,000
Q4 2022 Feb 13, 2023	SELL	$4.11 - $8.14 $20.5 Million - $40.6 Million	-4,989,565 Reduced 99.9%	5,140 $22,000
Q3 2022 Nov 10, 2022	BUY	$6.66 - $12.39 $701,844 - $1.31 Million	105,382 Added 2.16%	4,994,705 $37.6 Million
Q2 2022 Aug 12, 2022	SELL	$8.95 - $12.8 $14 Million - $20 Million	-1,564,431 Reduced 24.24%	4,889,323 $49.1 Million
Q1 2022 May 13, 2022	BUY	$10.05 - $22.48 $7.29 Million - $16.3 Million	725,638 Added 12.67%	6,453,754 $79.9 Million
Q4 2021 Feb 14, 2022	SELL	$17.78 - $33.08 $64.1 Million - $119 Million	-3,607,946 Reduced 38.65%	5,728,116 $131 Million
Q3 2021 Nov 15, 2021	BUY	$10.93 - $23.55 $8.89 Million - $19.1 Million	813,055 Added 9.54%	9,336,062 $207 Million
Q2 2021 Aug 13, 2021	BUY	$10.0 - $14.52 $85.2 Million - $124 Million	8,523,007 New	8,523,007 $110 Million

Others Institutions Holding AUPH

# of Institutions

268

Shares Held

69.3M

Call Options Held

984K

Put Options Held

574K

View Full List

About Aurinia Pharmaceuticals Inc.

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $2.18B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

More about AUPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account